Ontario Supports Life Sciences Innovation in Toronto

Province Partners with Apotex to Invest in New Technology

 Ontario is partnering with Apotex Inc. to invest in new technology and product development at its Etobicoke facility, creating 325 new jobs and retaining 1,265 positions.Shafiq Qaadri, MPP for Etobicoke North, and Yvan Baker, MPP for Etobicoke Centre, made the announcement today on behalf of Brad Duguid, Minister of Economic Development and Growth.

Apotex is the largest Canadian-owned pharmaceutical company and also among the country’s top pharmaceutical spenders on R&D. The company develops, manufactures and distributes more than 300 generic, affordable pharmaceuticals that are exported to 115 countries worldwide.

With support from Ontario’s Jobs and Prosperity Fund, the company is investing in new manufacturing technology and processes that will expand the company’s product range and enhance productivity.

Strengthening Ontario’s life sciences sector is part of our plan to create jobs, grow our economy and help people in their everyday lives.

Quick Facts

Additional Resources


Brad Duguid

“Ontario’s broad and innovative life sciences sector is a cornerstone of the province’s knowledge economy and also contributes to improving lives around the world. Through this strategic partnership, Apotex will boost its competitiveness, create jobs and reinforce its position as a key anchor company in Ontario’s life sciences cluster.”

Brad Duguid

Minister of Economic Development and Growth

Dr. Shafiq Qaadri

“Apotex has been part of the Etobicoke North community for many years now, and with this support from Ontario’s Jobs and Prosperity Fund it will be able to continue to develop affordable and quality medicine for the global market.”

Dr. Shafiq Qaadri

MPP for Etobicoke North

“As a proudly Canadian global pharmaceutical company, we take pride in our long history of investment in Ontario. From research and development, to manufacturing and packaging, our highly skilled workforce is key to delivering on our purpose of providing access to affordable, high quality and innovative healthcare solutions.”

Dr. Jeremy B. Desai

CEO and President, Apotex

Be the first to comment

Leave a Reply

Your email address will not be published.